Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | NQO1 | P15559 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29554780 | 1.00 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL29580834 | 1.00 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL28077721 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| Chrysene SCHEMBL27616409 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL27740850 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| Phenanthrene SCHEMBL27372954 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL2089665 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL30928215 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL21176632 | 0.96 | HPRT1 (0.54) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 | |
| SCHEMBL30329691 | 0.94 | HPRT1 (0.52) | HPRT1ALDH1A1HSD17B10MAPTCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-5480913-A | DIHYDRO-PHENANTHRENE DERIVATIVES, SIDE EFFECT REDUCTION | ARCH DEVELOPMENT CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| EP-0363128-B1 | ANTI-ANDROGEN COMPOUNDS | ARCH DEVELOPMENT CORPORATION (US) | 1993-09-01 | — | — | EP | disclosed |
| US-5208263-A | Dihydrophenanthrene derivatives | ARCH DEVELOPMENT CORPORATION (US) | 1993-05-04 | — | — | US | disclosed |
| US-5047304-A | Azo Pigment as Charge Generating Substance | CANON KABUSHIKI KAISHA (JP) | 1991-09-10 | — | — | US | disclosed |
| EP-0363128-A2 | Anti-androgen compounds | ARCH DEVELOPMENT CORPORATION (US) | 1990-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | HPRT1 3652/4885ALDH1A1 3874/4885HSD17B10 1170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.